PharmaShots | Incisive News in 3 Shots

Subscribe Now

Esophageal Squamous

BMS' Opdivo (nivolumab) Receives the US FDA's Approval for Advanced Esophageal Squamous Cell Carcinoma

BMS' Opdivo (nivolumab) Receives the US FDA's Approval for Advanced Esophageal Squamous Cell Carcinoma

June 11, 2020

Innovent and Eli Lilly Report Results of TYVYT (sintilimab) in P-II ORIENT-2 Study as 2L Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Innovent and Eli Lilly Report Results of TYVYT (sintilimab) in P-II ORIENT-2 Study as 2L Treatment for Advanced or Metastatic Esop...

May 14, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us